<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>10886704082750</udiDi>
    <basicUdiDi>0886704a00017JP</basicUdiDi>
    <tradeName>EMBOGUARD balloon guide catheter</tradeName>
    <deviceName>EMBOGUARD Balloon Guide Catheter</deviceName>
    <manufacturerName>Neuravi Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000007612</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020103</emdnCode>
    <emdnDescription>VASCULAR OCCLUSION CATHETERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BG8795C</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-23T08:29:18.694Z</lastUpdated>
  </row>
  <row>
    <udiDi>10886704082767</udiDi>
    <basicUdiDi>0886704a00017JP</basicUdiDi>
    <tradeName>EMBOGUARD balloon guide catheter</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Neuravi Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000007612</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>C0104020103</emdnCode>
    <emdnDescription>VASCULAR OCCLUSION CATHETERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BG8785C</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-23T08:27:23.948Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-IEMF00000761200000258</udiDi>
    <basicUdiDi>B-IEMF00000761200000258</basicUdiDi>
    <tradeName>EMBOTRAP II</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Neuravi Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000007612</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>C019010</emdnCode>
    <emdnDescription>INTRAVASCULAR RECANALISATION SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ET-007-521</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:05:43.415Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-IEMF00000761200000156</udiDi>
    <basicUdiDi>B-IEMF00000761200000156</basicUdiDi>
    <tradeName>EMBOTRAP II</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Neuravi Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000007612</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>C019010</emdnCode>
    <emdnDescription>INTRAVASCULAR RECANALISATION SYSTEMS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ET-007-533</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-13T22:05:42.611Z</lastUpdated>
  </row>
</eudamedExport>